BrainScape Medical
Debt Financing in 2025
BrainScape Medical is a Swiss life sciences startup focused on developing an end-to-end solution for brain disorder management and care, addressing many limitations of current approaches.
AnimalCare Engineering
Grant in 2025
AnimalCare Engineering dedicated to enhancing the quality of life for pets through innovative health monitoring technology. Its cutting-edge devices empower pet owners and veterinarians with real-time insights, ensuring the best possible care.
EarlySight
Debt Financing in 2025
EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.
FlowRide provides a more fluid and efficient transportation alternative.
Immitra Bio
Debt Financing in 2025
Immitra Bio is a biotechnology company developing a proprietary genetic medicine platform that combines hematopoietic stem cells (HSCs) and CRISPR-Cas9 gene editing. This innovative approach enables precise, long-term gene alterations within blood stem cells, offering transformative treatments for rare blood disorders with significant unmet medical needs.
Miloo
Debt Financing in 2025
Miloo is a Swiss-quality electric mobility company that designs and manufactures high-performance electric bikes for urban transport. Its e-bikes are engineered to go the extra mile with style, power, and a bold attitude, and are assembled in Switzerland to meet high safety and performance standards. Miloo aims to redefine urban mobility by offering a connected, capable, and enjoyable riding experience that provides more range, comfort, and freedom for daily commutes. The company emphasizes sustainable travel through electric two-wheel vehicles, combining visionary engineering with digital tools and attentive service to deliver an extra mile on every ride and help riders move through cities effortlessly.
Adoram Therapeutics
Pre Seed Round in 2025
Adoram Therapeutics specializes in developing innovative therapies for patients with immune-based diseases or solid tumors. The company leverages allosteric biochemistry to create novel treatments, focusing on small molecule immunotherapy to address unmet needs in the field of onco-immunology.
Cerret
Funding Round in 2025
Cerret, a Swiss-based jewelry brand, specializes in designing and manufacturing smart bracelets for women's safety. Their products, equipped with advanced technology, allow users to discreetly alert loved ones or authorities in case of an emergency, providing a sense of security and peace of mind.
Effetto Venturi
Debt Financing in 2024
Effetto Venturi specializes in the production of autonomous, lightweight buoys. These buoys, equipped with electric thrusters and remote control capabilities, can maintain precise positions in water without the need for anchoring. They are designed for various applications, including temporary water separation, event management, port activities, and water monitoring.
The ShowCase
Debt Financing in 2024
The ShowCase offers revolutionary portable studio system for exhibiting luxury products.
Astrocyte
Debt Financing in 2024
Astrocyte is a brain-penetrant inhibitor to improve memory function.
Dyneo Technologies
Debt Financing in 2024
Dyneo Technologies specializes in data-driven solutions for district heating and cooling networks. The company offers a Software as a Service (SaaS) platform that helps operators enhance energy efficiency and increase the use of renewable energy sources. Dyneo's technology enables operators to identify and address performance-degrading issues at scale, while also providing autonomous optimization to improve the profitability and sustainability of their thermal networks.
Adoram Therapeutics
Debt Financing in 2024
Adoram Therapeutics specializes in developing innovative therapies for patients with immune-based diseases or solid tumors. The company leverages allosteric biochemistry to create novel treatments, focusing on small molecule immunotherapy to address unmet needs in the field of onco-immunology.
Alpes-éco
Debt Financing in 2024
Alpes-éco Suisse specializes in developing smart herd management solutions for farmers. Their primary product is livestock management software, which optimizes daily animal care, including milk production control and health evaluation. The company's connected devices, accessible via smartphones, enable efficient management of livestock, even in remote areas, thereby enhancing sustainability and efficiency in the agricultural sector.
Neurovia Bioelectronics
Grant in 2024
Neurovia Bioelectronics is revolutionizing blood pressure management by offering innovative solutions to improve health outcomes and quality of life. It utilizes established microfabrication technologies and 3D manufacturing techniques to create endovascular stimulation devices
Wyss Center
Debt Financing in 2024
Epios personalized and precision management of brain disorders using daily life monitoring and therapeutics. The Epios system comprises a series of thin leads incorporating sensing electrodes and a miniature implant, inserted beneath the skin. The neural signals are wirelessly transmitted to an external receiver held in place on the skin directly over the implant with a magnet, and from there are conveyed to a wearable data processor and are finally securely stored in the Epios Cloud.
HekeTiss
Debt Financing in 2024
HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.
Azure Cell Therapies
Grant in 2024
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
Firefly Fusion
Grant in 2024
FireFly Fusion is a research company focused on advancing fusion energy technology to create clean and sustainable power through controlled nuclear reactions. The company is pioneering the development of standard tokamaks, a type of device used to confine hot plasma and facilitate fusion. By utilizing microwaves to generate and control this plasma, FireFly Fusion aims to harness the inherent energy of fusion, positioning itself as a complementary solution to renewable energy sources. Its efforts are directed towards enabling organizations, governments, and industries to transition toward a more sustainable energy future, utilizing proven technologies combined with innovative scientific advancements.
Antion Biosciences
Debt Financing in 2024
Antion Biosciences is a Geneva-based biotechnology company focused on cell and gene engineering to develop off-the-shelf therapies for diseases with significant unmet medical needs. Its proprietary technology enables multiplexed, modular modification of therapeutic cells, supporting allogeneic approaches and the potential to enhance safety and efficacy of next-generation therapies. The company is repurposing its miCAR19 programs for autoimmune diseases and advancing its lead product miCAR7, backed by in vivo proof-of-concept data. By leveraging multiplex engineering, Antion aims to deliver best-in-class treatments for B-cell-driven autoimmune conditions, with notable preclinical progress and human proof-of-concept milestones to date.
Nsave is a fintech startup that specializes in digital banking services, focusing on providing a secure platform for saving in various currencies, including USD, EUR, and GBP. The company aims to enhance financial inclusion by offering services that do not impose account restrictions, allowing customers to access global safe accounts for their funds. With a commitment to financial security, Nsave ensures that users can manage their savings with confidence and ease.
HeroSupport
Seed Round in 2024
HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.
Transmutex
Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.
Carrat Sàrl
Seed Round in 2023
Carrat Sàrl is a company that makes bracelets that send an emergency call with the press of a button.
MPC Therapeutics
Debt Financing in 2023
MPC Therapeutics is a biotechnology company focused on developing life-altering medications for patients with cancer and degenerative disorders. It specializes in creating compounds that modify mitochondrial processes to prevent disease growth.
EarlySight
Debt Financing in 2023
EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.
KYLYS
Debt Financing in 2023
Founded in Geneva in 2017, KYLYS is a Swiss company specializing in biomolecule-based products. It offers innovative, safe, and effective solutions for medical, surgical, and cosmetic needs, with a focus on hyaluronic acid pearls.
FluoSphera
Debt Financing in 2023
FluoSphera is a biotechnology company focused on developing safer and more effective drugs. It aims to minimize adverse side effects and reduce reliance on animal testing by leveraging innovative drug discovery technologies. This enables FluoSphera's partners to better understand human physiological responses and safeguard populations from harmful chemicals more efficiently.
Consulto intends to change the way outpatient care is delivered by extending team-based care beyond hospital walls.
Plair SA
Debt Financing in 2023
Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.
Endotelix
Debt Financing in 2023
Endotelix is a Swiss biotechnology company and a spin-off from the University of Geneva focused on antiphospholipid syndrome. It develops diagnostic tests and treatment options, aiming to deliver fast, sensitive solutions for the condition. The company provides diagnostic tools, therapies, and supports clinical research to assist clinicians in diagnosing antiphospholipid syndrome and identifying effective treatments.
Ovomind
Seed Round in 2022
Ovomind develops emotion-aware gaming technology that adds a new dimension to how video games are shared and played. The company designs smart wristbands that classify players' emotions from biosignals and transmit the data to the cloud, where an algorithm adjusts game sequencing in real time to create a dynamic, personalized emotional overlay for games and streams. By centering human emotion in gameplay, Ovomind aims to deliver a more immersive and interactive user experience.
Terapet
Debt Financing in 2022
Terapet specializes in advanced proton therapy for cancer treatment. Founded by physicists Christina Vallgren, Marcus Palm, and Professor Raymond Miralbell from Geneva University Hospitals, the company offers precise radiotherapy that minimizes harm to healthy cells. Incorporated in 2019, Terapet is based in Geneva, Switzerland.
EBAMed
Debt Financing in 2022
EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.
iOnctura
Debt Financing in 2022
iOnctura is a biopharmaceutical company specializing in the development of novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which plays a significant role in cancer progression. The company seeks to enhance existing immune checkpoint therapies by creating new drugs that, when used in conjunction with these therapies, may improve safety and efficacy for cancer patients. iOnctura has formed strategic partnerships with prominent organizations, including Merck and Cancer Research Technology, to advance a pipeline of preclinical molecules toward clinical application. With access to advanced drug discovery labs and a network of academic collaborators, iOnctura is well-equipped to develop innovative combination therapies in the realm of cancer immunology, ultimately striving to optimize treatment outcomes for patients.
V-Labs
Debt Financing in 2022
V-Labs is a technology company specializing in augmented reality solutions for excavation projects. It develops advanced augmented reality technology tailored for geospatial headsets, allowing users to visualize complex data directly at the worksite with centimeter accuracy. This innovative approach includes a local positioning system that enhances operational efficiency by minimizing risks of damage to underground infrastructure. By providing real-time visual guidance, V-Labs enables operators and contractors to expedite excavation processes while ensuring safety and precision in their work.
Deasyl
Debt Financing in 2022
Deasyl is a company dedicated to the development of innovative and eco-friendly chemical solutions, focusing on green chemistry and recycling processes. It specializes in transforming waste and biomass into sustainable products, utilizing clean technology to create scalable processes for major players in the fine chemical and petrochemical industries. By advancing waste valorization and employing biodiesel production methods, Deasyl enables its clients to adopt environmentally friendly practices, thereby contributing to a more sustainable future.
GliaPharm
Debt Financing in 2022
GliaPharm is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders by targeting glial cells to support brain metabolism. It has developed the GliaX platform to identify drugs that modulate glial activity and energy metabolism. The platform combines high-throughput screening using enzymatic and primary-cell assays with metabolic characterization of compounds in vitro in primary brain cell cultures and in vivo in rodent brains. Research includes various rodent models of brain aging, Alzheimer's disease, and ALS, with selective contract research organizations handling parts of the drug-development process. Founded in 2016 and based in Geneva, GliaPharm pursues glia-mediated neuroprotection and maintenance of cognitive function.
Transmutex
Debt Financing in 2022
Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.
Impaakt
Debt Financing in 2022
Founded in 2017, Impaakt is a Swiss-based company that offers a collaborative platform leveraging collective intelligence to assess and report on the social and environmental impact of companies. It provides standardized impact reports, data analytics tools, and virtual portfolio management solutions for asset managers.
Diabeto is a biopharmaceutical start-up project spinning off the University of Geneva and based on pioneering expertise in discovery of mechanisms sustaining life without insulin.
ORamaVR
Debt Financing in 2022
ORamaVR is a pioneering company focused on transforming medical training through virtual reality (VR) technology. It offers an innovative IT platform, MAGES-SDK, that enables medical organizations to create high-fidelity VR simulations for training purposes at significantly reduced costs and time compared to traditional methods. These simulations are utilized by hospitals, medical schools, and training centers to effectively train and assess medical professionals. The platform's efficacy is supported by numerous clinical trials and scientific publications, with endorsements from prestigious institutions such as the USC Keck School of Medicine, NYU Langone Medical School, and the University of Geneva. ORamaVR has received multiple international awards for its societal impact and has established partnerships with notable organizations, including Airbus and Microsoft. The company has also secured significant venture capital funding from strategic investors, enhancing its position in the field of medical VR training.
Adiposs
Seed Round in 2021
Adiposs is a clinical-stage life science company developing innovative medical imaging products. Its flagship technology enables the early detection of cachexia, a debilitating body-wasting syndrome associated with cancer and other chronic diseases.
HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.
ABCDx
Convertible Note in 2021
ABCDx is a Geneva-based company that develops and validates biomarker panels and related diagnostics for brain injury care. It aims to identify patients at risk of severe long-term complications after traumatic brain injury or stroke and to educate clinicians on using these tests. The company is building a platform that analyzes brain biomarkers from a finger-prick blood sample to enable rapid, point-of-care diagnosis of brain injuries, supporting timely treatment decisions. Founded in 2014 by researchers from the University of Geneva and related institutes, ABCDx translates biomarker discovery and clinical validation into practical tools for stroke and brain injury management.
Neurosoft Bioelectronics
Convertible Note in 2021
Neurosoft Bioelectronics specializes in developing soft, implantable electrodes designed to interface with nervous tissues. Their flagship product, SOFT ECoG, is a subdural electrode used for recording and stimulating the brain's surface, offering improved recordings, reduced current speed, minimized MRI artifacts, enhanced bio-integration, and precise anatomical targeting.
The Content Engine
Debt Financing in 2021
The Content Engine operates a technology platform that merges machine‑learning tools with editorial expertise to deliver high‑quality content at scale. Its workflow system streamlines ideation, commissioning, production, approvals, and distribution, enabling organisations to publish audience‑engaging material daily across multiple channels. The platform functions as a creativity network, connecting creators and clients to produce tailored content that supports global audience growth and impact.
FluoSphera is a biotechnology company focused on developing safer and more effective drugs. It aims to minimize adverse side effects and reduce reliance on animal testing by leveraging innovative drug discovery technologies. This enables FluoSphera's partners to better understand human physiological responses and safeguard populations from harmful chemicals more efficiently.
HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.
Adiposs
Debt Financing in 2021
Adiposs is a clinical-stage life science company developing innovative medical imaging products. Its flagship technology enables the early detection of cachexia, a debilitating body-wasting syndrome associated with cancer and other chronic diseases.
ORamaVR
Funding Round in 2020
ORamaVR is a pioneering company focused on transforming medical training through virtual reality (VR) technology. It offers an innovative IT platform, MAGES-SDK, that enables medical organizations to create high-fidelity VR simulations for training purposes at significantly reduced costs and time compared to traditional methods. These simulations are utilized by hospitals, medical schools, and training centers to effectively train and assess medical professionals. The platform's efficacy is supported by numerous clinical trials and scientific publications, with endorsements from prestigious institutions such as the USC Keck School of Medicine, NYU Langone Medical School, and the University of Geneva. ORamaVR has received multiple international awards for its societal impact and has established partnerships with notable organizations, including Airbus and Microsoft. The company has also secured significant venture capital funding from strategic investors, enhancing its position in the field of medical VR training.
Ovomind
Pre Seed Round in 2020
Ovomind develops emotion-aware gaming technology that adds a new dimension to how video games are shared and played. The company designs smart wristbands that classify players' emotions from biosignals and transmit the data to the cloud, where an algorithm adjusts game sequencing in real time to create a dynamic, personalized emotional overlay for games and streams. By centering human emotion in gameplay, Ovomind aims to deliver a more immersive and interactive user experience.
CommoChain
Pre Seed Round in 2019
Founded in 2018, CommoChain specializes in developing a platform for commodity trading. It enhances transaction security through blockchain and smart contract technology, streamlining back-office operations for exporters and importers of commodities and raw materials.
MagicTomato
Venture Round in 2019
MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.
Quantum Integrity
Seed Round in 2018
Quantum Integrity SA is a Swiss company based in Geneva, founded in 2017, that specializes in software development for forensic analysis of digital images. The company's technology examines images on a pixel-by-pixel basis to identify manipulations and potential forgeries, regardless of the methods or software employed in their alteration. By focusing on accuracy in forgery detection, Quantum Integrity enhances the security of cyber communications and ensures the integrity of digital media.
Tokenestate.io
Seed Round in 2018
Tokenestate SA is a Swiss-based company that provides a security token issuance and management platform designed for investments in private companies and real estate. Founded in 2017 and located in Geneva, the platform leverages blockchain and digital signature technologies to facilitate fundraising, manage the buying and selling of shares, and conduct KYC and anti-money laundering checks. Additionally, Tokenestate offers Tokenization as a Service (TaaS) for real estate funds, enabling a marketplace for tokenized assets. The company's services streamline the management of securities and enhance the investor experience in the evolving landscape of digital finance.
Founded in 2015, Kejako is a Swiss medical device company specializing in ophthalmic surgery. It develops non-invasive solutions to address presbyopia, a gradual loss of visual accommodation, using advanced numerical simulations for personalized treatment.
Cleverdist
Funding Round in 2017
Cleverdist designs and develops supervisory control and data acquisition systems for industrial control, including solutions for CERN. The company offers conceptual design, prototyping, architecture, system integration, and supervisory systems, as well as training and staffing services. Its focus is on integrating control and automation technologies across industries to enable efficient technology transfer.
Alohi is a Swiss company founded in 2015 that offers a cloud-based communication platform tailored for entrepreneurs, small businesses, and individual consumers. The company provides a range of services, including local phone numbers in various countries, customizable greeting messages, call forwarding, voicemail, fax, and announcements. Alohi focuses on two primary platforms: one for self-service communications and another for legally binding electronic signatures. Its current products include Sign.Plus, Fax.Plus, and Scan.Plus, which facilitate electronic signing and verification of documents as well as secure online fax services. By enabling users to communicate efficiently and manage confidential documents safely, Alohi aims to enhance the way individuals and businesses interact.
MagicTomato
Seed Round in 2017
MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.
Quantreex
Pre Seed Round in 2017
Founded in 2016, Quantreex offers a web-based trading platform that enables users to create automated trading strategies using artificial intelligence and machine learning. The platform designs strategies, verifies them through back tests on multiple instruments and markets, and allows clients to deploy these strategies live.
Gmelius
Pre Seed Round in 2017
Gmelius develops a software extension that transforms email inboxes into collaborative workspaces. It automates workflows, enables real-time team collaboration, and integrates with other tools like Slack or Trello. Founded in 2016, Gmelius is headquartered in Switzerland and serves over 10,000 paid customers, including notable companies such as Netflix.
ProtonVPN
Seed Round in 2017
ProtonVPN is Swiss-based VPN service, created by the same team of CERN scientists who created ProtonMail. ProtonVPN makes it possible to access the Internet without censorship and surveillance.
TwentyGreen
Seed Round in 2016
TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements aimed at enhancing sustainable animal farming practices. Founded in 2015 and based in Root, Switzerland, the company has developed a unique triple active probiotic product that addresses challenges faced in intensive animal farming, such as improving digestion, enhancing feed conversion ratios, and reducing disease and pollution. The probiotic supplement is grounded in research from the École Polytechnique Fédérale de Lausanne, focusing on the enhancement of gut microbiota, which is crucial for food metabolism and immune defense. Targeting animal farmers, feed suppliers, and large retailers, TwentyGreen aims to capture a 10% share of the rapidly growing global animal feed probiotic market, which exceeds $4 billion annually. The commercialization of their product involves rigorous research and development in collaboration with esteemed academic partners to meet regulatory standards for animal feed.
OrbiWise
Angel Round in 2016
OrbiWise is a Swiss company specializing in advanced technologies for the Internet of Things (IoT) sector. Its primary product, OrbiWAN, is a carrier-grade network server designed for networks utilizing LoRa technology. This server enhances the performance of IoT services by enabling real-time device messaging and targeted device group profiling, effectively supporting a wide range of applications from smart city initiatives to rural and industrial environments. With a strong engineering foundation, OrbiWise's team possesses extensive expertise in wireless technology, cloud and embedded software, communication systems, and RF/hardware design. The company is committed to customer success and values innovation, technology, and integrity in all its operations.
Prodibi
Seed Round in 2016
Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.
IPStock
Seed Round in 2016
The team of IPDM have worked in the Global Stock Image market for over 5 years. They has successfully created the world’s #1 ranked portfolio of vector images Macrovector, world’s most popular cloud service for photographers and artists IPSTOCK.COM, and a premium marketplace for vector illustrations Vectorplace.com. The new IPStock solution is a blockchain ecosystem designed for all marketplaces, content creators and consumers, content registry on blockchain and license management through smart-contracts.
Expedismart
Seed Round in 2016
Expedismart operates a comparison platform for courier services, enabling users to select the most suitable option based on quality, accuracy, preferred time, and price. The platform facilitates online booking for transporting parcels within Switzerland or internationally.
Ifluenz
Seed Round in 2016
Ifluenz is an Instagram influencer marketing platform designed to connect advertisers with influential Instagram users. The company focuses on integrating influencers into campaign planning to ensure that brands and products are authentically represented. By leveraging advanced algorithms, Ifluenz reviews, sorts, and classifies influencers based on various criteria, allowing brands to select the most suitable influencers for their marketing campaigns. This approach facilitates effective product placement and enhances brand visibility, enabling advertisers to promote their offerings to a global audience.
Silver Wave Medical
Seed Round in 2016
Silver Wave is a Swiss company based in Geneva, founded by expert professionals from the pharma & medical device industries.
Building on 25 years of experience, the team at Silver Wave has a leading reputation in the field of aesthetics, with experience in research and development as well as manufacturing and management that extends to many global healthcare companies. Silver Wave is built on the team’s experience and passion.
Goodwall
Angel Round in 2015
Goodwall is a digital platform for students and young professionals that serves as a professional social network and online community to connect, develop skills, and access opportunities. Users create profiles to showcase grades, achievements, skills, and ideas to universities and employers, and can discover jobs, internships, scholarships, and volunteer events. The platform is designed to meet the needs of Gen Z and millennials, offering opportunities aligned with users' preferences and potential to help prepare for future careers and address societal challenges. Based in Geneva, Switzerland, Goodwall was founded in 2014.
Multiwave Technologies
Seed Round in 2015
Multiwave Technologies develops breakthrough magnetic resonance imaging and positron emission tomography devices, including metamaterial MRI antennas designed by its French unit. The company aims to improve MRI image quality and support clinical decision making, including portable MRI capabilities and sensor-based performance analysis. Founded in 2015 in Switzerland, it is headquartered in Geneva and conducts research and development in France, reflecting an international footprint. The business is recognized for its metamaterial MRI antenna design and positions itself as a deep science imaging innovator in neurology and other medical imaging applications.
Planet Intus
Seed Round in 2015
Planet Intus SA is a Swiss company specializing in the design and development of indoor geolocation software. Founded in 2014 and headquartered in Carouge, Switzerland, the company leverages a combination of French telecommunications expertise and Swiss quality standards. Planet Intus provides both active and passive geolocation infrastructure, enabling a variety of indoor guidance services and applications for end users. Its offerings include preparation and navigation assistance, opportunity tracking, safety services, and marketing data analysis for professionals, enhancing customer experience in sectors such as retail, leisure, travel, and healthcare. The company's innovative 3D-integrated platform utilizes indoor positioning technologies and user behavior analysis, allowing clients to navigate locations like exhibitions efficiently. A team of skilled engineers and technicians supports Planet Intus, focusing on Geographic Information Systems, mobile app development, and big data analytics to deliver superior operational insights and profitability for businesses.
InvestGlass
Seed Round in 2015
InvestGlass is a Swiss-based company founded in 2013, specializing in the development of a web-based platform that provides a comprehensive suite of tools for client and customer management, particularly in the financial sector. The platform integrates features such as digital onboarding, customer relationship management, portfolio management, and marketing automation, all designed to enhance operational efficiency for financial institutions and advisors. InvestGlass also offers a Strategy Tutor to assist investors in maintaining their investment strategies, alongside access to global market data, news, and forecasts. Additionally, an Educational Portal provides resources such as articles, tools, and videos aimed at improving market understanding. By leveraging artificial intelligence and a secure Swiss cloud infrastructure, InvestGlass helps clients navigate compliance challenges while focusing on delivering high-quality investment advice.
Proton Mail
Venture Round in 2015
Proton Mail is a free and secure email service that is powered by community, not surveillance capitalism. Its free plan is supported by paid subscriptions that offer extra features and storage. With Easy Switch, you can quickly migrate from any email provider to Proton Mail. It helps to import emails, labels, contacts, and calendars to Proton Mail and set up automatic forwarding to receive future emails in the new encrypted inbox.
ProtonMail Customer Care
Seed Round in 2015
Protonmail has revolutionized the email industry by providing secure and private email services, ensuring the privacy of its users. The customer support team of Protonmail plays a crucial role in maintaining the trust of the users by providing instant resolutions to their queries. The users can contact the Protonmail support team via email, chat, or the Protonmail Customer Care Number to resolve any issue related to Protonmail. With Protonmail, users can communicate conveniently and securely, leaving no room for data breaches.
Telexoo
Seed Round in 2014
Telexoo is a Geneva-based company that offers an online financial platform for currency exchange at competitive rates. Unlike traditional services, Telexoo provides a more personal approach, allowing users to connect directly with exchange specialists via phone or email, eliminating the need for call centers or ticket systems. Users can create a free account on the platform to transfer funds from their bank for exchange. The transactions are executed in real-time based on the interbank rate, enabling users to send exchanged currency seamlessly to any destination. Telexoo focuses on providing accessible and efficient currency exchange services.
Aptissen
Seed Round in 2014
Aptissen SA, founded in 2013 as a spin-off of ANTEIS, is a Swiss company based in Plan-les-Ouates, specializing in the development and commercialization of hyaluronic acid polymer-based injectable medicinal products. The company focuses on aesthetic medicine, ophthalmology, and orthopedics, with notable innovations such as the Synolis VA range, which combines hyaluronic acid and sorbitol to provide rapid mobility recovery and effective pain relief for osteoarthritis patients. Aptissen also offers a food supplement called Cartylis aimed at joint health. Its products are distributed through a global network of distributors in over 50 countries, including Europe, South America, Canada, the Middle East, and Asia. The company operates subsidiaries in Italy, Poland, and France, and maintains certifications including CE, ISO13485, MDSAP, and GMP compliance, ensuring adherence to high-quality standards. Aptissen relies on subcontracting for production, sourcing materials from three suppliers located in Europe.
nyce is a disruptive online Art Gallery collaborating with pioneering Artists producing their debut Art sculptures while exploring new territories.
Cleverdist
Seed Round in 2014
Cleverdist designs and develops supervisory control and data acquisition systems for industrial control, including solutions for CERN. The company offers conceptual design, prototyping, architecture, system integration, and supervisory systems, as well as training and staffing services. Its focus is on integrating control and automation technologies across industries to enable efficient technology transfer.
Faveeo SA, established in 2012 and headquartered in Geneva, Switzerland, specializes in collaborative intelligence solutions for large organizations. The company offers an integrated suite of tools designed to manage internal and external data streams effectively. Faveeo's platform automatically identifies key concepts, sources, and people relevant to any topic or industry, facilitates content curation and analysis, and enables seamless collaboration and publishing. Its solutions are employed for media monitoring, competitive intelligence, market research, social media engagement, and content marketing applications across various sectors, including research centers, NGOs, and international groups.
ProtonMail Customer Care
Grant in 2013
Protonmail has revolutionized the email industry by providing secure and private email services, ensuring the privacy of its users. The customer support team of Protonmail plays a crucial role in maintaining the trust of the users by providing instant resolutions to their queries. The users can contact the Protonmail support team via email, chat, or the Protonmail Customer Care Number to resolve any issue related to Protonmail. With Protonmail, users can communicate conveniently and securely, leaving no room for data breaches.
V-Labs is a technology company specializing in augmented reality solutions for excavation projects. It develops advanced augmented reality technology tailored for geospatial headsets, allowing users to visualize complex data directly at the worksite with centimeter accuracy. This innovative approach includes a local positioning system that enhances operational efficiency by minimizing risks of damage to underground infrastructure. By providing real-time visual guidance, V-Labs enables operators and contractors to expedite excavation processes while ensuring safety and precision in their work.